Fresenius Medical Care (FMS) Q3 results ((€)): Revenues: 4,419M (+8.9%); Health Care Services: 3,492M (+7.2%); Health Care Products: 927M (+15.9%).
Net Income: 333M (+16.8%); EPS: 1.10 (+18.3%); non-GAAP Net Income: 363M (+5.8%); non-GAAP EPS: 1.21 (+8.0%); CF Ops: 868M (+15.3%).
2019 Outlook: Adjusted net income to develop in the range of (2%) to 2% (unch).
2020 Outlook: Adjusted net income to grow at a mid to high single digit rate.
Shares are up 5% premarket.
Previously: Fresenius Medical Care EPS beats by €0.11, revenue in-line (Oct. 29)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.